PATENT CLAIM ANALYSIS

Application Number: 16064692
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "265100"]

Abstract:
Disclosed is an antitumor effect potentiator for one or more other compounds having an antitumor effect, the antitumor effect potentiator comprising a novel pyrrolopyrimidine compound.

Claim (Index 16):
The use according to  claim 13 , wherein the one or more other compounds having an antitumor effect are one or more members selected from the group consisting of kinase inhibitors, apoptosis inducers, nuclear receptor modulators, immunomodulators, nuclear export signal inhibitors, proteasome modulators, DNA-damaging agents, antimetabolites, platinum-based antitumor agents, microtubule inhibitors, alkylating agents, and anthracycline-based antitumor agents.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 94.0
- Lexical Diversity: 1.28571
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15122863', '15890470', '15708917', '15756366', '12310597']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8007359936260601
- 35 USC 102 Novelty (BERT): 0.5653463807967791
- Combined Prediction Score: 0.7771970323431321
- Mean Citation Score: 357.162248
- Max Citation Score: 477.41696
- Similarity Product: 316.099769304657

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test